| Adherencia y persistencia terapéutica: causas, consecuencias y estrategias de mejora T Dilla, A Valladares, L Lizán, JA Sacristán Atención primaria 41 (6), 342, 2009 | 466 | 2009 |
| Allopurinol hypersensitivity syndrome: a review F Arellano, JA Sacristán Annals of Pharmacotherapy 27 (3), 337-343, 1993 | 454 | 1993 |
| Problems and solutions in calculating quality-adjusted life years (QALYs) L Prieto, JA Sacristán Health and quality of life outcomes 1, 1-8, 2003 | 453 | 2003 |
| ¿ Qué es una tecnología sanitaria eficiente en España? JA Sacristán, J Oliva, JD Llano, L Prieto, JL Pinto Gaceta Sanitaria 16, 334-343, 2002 | 395 | 2002 |
| Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients JA Sacristán BMC medical informatics and decision making 13, 1-8, 2013 | 356 | 2013 |
| Patient involvement in clinical research: why, when, and how JA Sacristán, A Aguarón, C Avendaño-Solá, P Garrido, J Carrión, ... Patient preference and adherence, 631-640, 2016 | 355 | 2016 |
| What is an efficient health technology in Spain? JA Sacristán, J Oliva, J Del Llano, L Prieto, JL Pinto Gaceta sanitaria 16 (4), 334-343, 2002 | 158 | 2002 |
| Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized … C Turbí, G Herrero-Beaumont, JC Acebes, A Torrijos, J Graña, R Miguélez, ... Clinical therapeutics 26 (2), 245-256, 2004 | 128 | 2004 |
| Farmacoeconomía: evaluación económica de medicamentos JAS del Castillo, XB Llach, JR Forns EDIMSA, 1995 | 123 | 1995 |
| Evaluation of pharmacoeconomic studies: utilization of a checklist JA Sacristán, J Soto, I Galende Annals of pharmacotherapy 27 (9), 1126-1133, 1993 | 115 | 1993 |
| The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study) JC Gomez, JA Sacristan, J Hernandez, A Breier, PR Carrasco, CA Saiz, ... Journal of Clinical Psychiatry 61 (5), 335-343, 2000 | 108 | 2000 |
| Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients L Prieto, JA Sacristán, JA Hormaechea, A Casado, X Badia, JC Gómez Current Medical Research and Opinion 20 (6), 827-835, 2004 | 99 | 2004 |
| Evaluación económica en medicina JA Sacristán, V Ortún, J Rovira, L Prieto, F García-Alonso Medicina clínica 122 (10), 379-382, 2004 | 98 | 2004 |
| Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias L Prieto, JA Sacristán, F Antoñanzas, C Rubio-Terrés, JL Pinto, J Rovira Medicina clínica 122 (13), 505-510, 2004 | 97 | 2004 |
| Metamizole: reassessment of its therapeutic role F Arellano, JA Sacristán European journal of clinical pharmacology 38, 617-619, 1990 | 92 | 1990 |
| Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study) I García-Cabeza, JC Gómez, JA Sacristán, E Edgell, ... BMC psychiatry 1, 1-8, 2001 | 86 | 2001 |
| A Rasch model analysis to test the cross‐cultural validity of the EuroQoL‐5D in the Schizophrenia Outpatient Health Outcomes Study L Prieto, D Novick, JA Sacristan, ET Edgell, J Alonso, SOHO Study Group Acta Psychiatrica Scandinavica 107, 24-29, 2003 | 85 | 2003 |
| Clinical research and medical care: towards effective and complete integration JA Sacristán BMC medical research methodology 15, 1-7, 2015 | 79 | 2015 |
| Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B. 1.1. 529) variant in Spain: a nationwide cohort study S Monge, A Rojas-Benedicto, C Olmedo, C Mazagatos, MJ Sierra, ... The Lancet Infectious Diseases 22 (9), 1313-1320, 2022 | 75 | 2022 |
| Treatment adherence and persistence: causes, consequences and improvement strategies T Dilla, A Valladares, L Lizan, JA Sacristán Atencion primaria 41 (6), 342-348, 2009 | 73 | 2009 |
Luis PrietoLondon School of Hygiene & Tropical Medicine在 lshtm.ac.uk 的电子邮件经过验证
